<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00832715</url>
  </required_header>
  <id_info>
    <org_study_id>2007-0387</org_study_id>
    <secondary_id>NCI-2015-01900</secondary_id>
    <nct_id>NCT00832715</nct_id>
  </id_info>
  <brief_title>Utility of Endobronchial Ultrasound Guided Needle Biopsy in Early Stage Non- Small Cell Lung Cancer (NSCLC)</brief_title>
  <official_title>Diagnostic Utility of Endobronchial Ultrasound Guided Mediastinal Lymph Node Sampling in Clinical Stage I and II Non Small Cell Lung Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this clinical research study is to learn how accurately an endobronchial&#xD;
      ultrasound transbronchial needle aspiration (EBUS -TBNA) may detect mediastinal lymph node&#xD;
      metastases in patients with clinical stage I and II non-small cell lung cancer (NSCLC).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Procedures:&#xD;
&#xD;
      A procedure called EBUS-TBNA has been developed that might allow doctors to get samples of&#xD;
      lymph glands without performing an operation. The standard practice is a surgical operation&#xD;
      called a mediastinoscopy. If researchers find out that EBUS-TBNA is as accurate as&#xD;
      mediastinoscopy, it may mean that patients with lung cancer can avoid having surgery or will&#xD;
      be able to get treatment before surgery.&#xD;
&#xD;
      EBUS-TBNA:&#xD;
&#xD;
      If you agree to take part in this study, you will first have an EBUS-TBNA. This will be&#xD;
      performed on an out-patient basis under general anesthetic. The doctor will examine your&#xD;
      lungs for suspicious lymph glands with an ultrasound, and then will take a sample of tissue&#xD;
      from the lymph gland. This will be done using a flexible scope called a bronchoscope that can&#xD;
      be passed into the windpipe. The lymph glands around the wind pipe can be seen and then&#xD;
      removed with a small needle. The procedure should take about 1 hour.&#xD;
&#xD;
      Researchers will then analyze the lymph glands that were removed. Depending on whether or not&#xD;
      the lymph glands have cancer in them, your doctor will then recommend the most appropriate&#xD;
      therapy for you. This may include mediastinoscopy or some other appropriate therapy.&#xD;
&#xD;
      All the data for the study will be stored with a password protected system.&#xD;
&#xD;
      Length of Study:&#xD;
&#xD;
      Your participation in this study will be over after you have completed EBUS-TBNA.&#xD;
&#xD;
      This is an investigational study. EBUS-TBNA is FDA approved for this procedure.&#xD;
&#xD;
      Up to 120 patients will take part in this study. All will be enrolled at MD Anderson.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Actual">July 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>Phase 1/Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants with False Negative Rate Using EBUS Guided Mediastinal Lymph Node Biopsy</measure>
    <time_frame>Patient participation 1 hour to complete EBUS-TBNA</time_frame>
    <description>False negative rate estimated using EBUS guided mediastinal lymph node biopsy following a negative positron emission tomography (PET) scan with a 90% credible interval.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Lung Cancer</condition>
  <arm_group>
    <arm_group_label>EBUS-TBNA</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Endobronchial Ultrasound Transbronchial Needle Aspiration (EBUS-TBNA)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>EBUS-TBNA</intervention_name>
    <description>Tissue sample collected bronchoscope using needle aspirate of lung lymph gland, procedure takes 1 hour.</description>
    <arm_group_label>EBUS-TBNA</arm_group_label>
    <other_name>Endobronchial Ultrasound Transbronchial Needle Aspiration</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Patient must be &gt;/= 18 years old.&#xD;
&#xD;
          2. Patient must have Eastern Cooperative Oncology Group (ECOG)/Zubrod status 0-2.&#xD;
&#xD;
          3. Patient must have proven or suspected NSCLC (squamous cell, adenocarcinoma, or large&#xD;
             cell) and be clinical Stage I or II, according to the 1998 staging system of the&#xD;
             American Joint Commission on Cancer for lung cancer (T1-3 N0, T1-2 N1).&#xD;
&#xD;
          4. Patient must be eligible for definitive surgical therapy for primary NSCLC.&#xD;
&#xD;
          5. Patient or the patient's legally acceptable representative must provide written&#xD;
             informed consent prior to registration and any study-related procedures.&#xD;
&#xD;
          6. If the patient is a survivor of a prior invasive cancer, all of the following criteria&#xD;
             must apply: a. Patient has undergone potentially curative therapy for all prior&#xD;
             malignancies. b. No evidence of active / recurrent disease.&#xD;
&#xD;
          7. All females of childbearing age must have a negative pregnancy test before beginning&#xD;
             the study.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient has received prior chemotherapy or radiotherapy for this cancer.&#xD;
&#xD;
          2. Patient is considered a poor risk for surgery due to non-malignant systemic disease&#xD;
             (cardiovascular, renal, etc.) that would preclude the treatment options.&#xD;
&#xD;
          3. Patient has contraindication to either endobronchial ultrasound or mediastinoscopy&#xD;
             such as: history of bleeding diathesis, latex allergy, mediastinoscopy, mediastinal&#xD;
             nodal resection, tracheostomy.&#xD;
&#xD;
          4. Patients malignancy consistent with well differentiated (carcinoid) neuroendocrine&#xD;
             histology.&#xD;
&#xD;
          5. Patient has two separate same histology lung tumors (where the question of two&#xD;
             separate primaries or metastatic disease makes definitive clinical staging&#xD;
             inaccurate).&#xD;
&#xD;
          6. Females who are pregnant and/or lactating.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>George A. Eapen, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Texas MD Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>University of Texas MD Anderson Cancer Center Website</description>
  </link>
  <verification_date>July 2016</verification_date>
  <study_first_submitted>January 29, 2009</study_first_submitted>
  <study_first_submitted_qc>January 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2009</study_first_posted>
  <last_update_submitted>July 18, 2016</last_update_submitted>
  <last_update_submitted_qc>July 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lung</keyword>
  <keyword>Lung Cancer</keyword>
  <keyword>NSCLC</keyword>
  <keyword>Non Small Cell Lung Cancer</keyword>
  <keyword>Squamous Cell</keyword>
  <keyword>Adenocarcinoma</keyword>
  <keyword>Large Cell</keyword>
  <keyword>Endobronchial Ultrasound Transbronchial Needle Aspiration</keyword>
  <keyword>Mediastinal lymph node negative disease</keyword>
  <keyword>Mediastinal Nodal Metastasis</keyword>
  <keyword>EBUS-FNA</keyword>
  <keyword>Endobronchial Ultrasound Fine Needle Aspiration</keyword>
  <keyword>EBUS guided needle mediastinal lymph node biopsy</keyword>
  <keyword>Biopsy</keyword>
  <keyword>PET scan</keyword>
  <keyword>Positron Emission Tomography</keyword>
  <keyword>CT Scans</keyword>
  <keyword>Computed Tomography Scans</keyword>
  <keyword>Lymph node</keyword>
  <keyword>Mediastinoscopy</keyword>
  <keyword>Bronchoscope</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

